Outcomes
The serological response using ELISA F29 over time and the incidence rate of seronegative conversion measured by ELISA F29 were evaluated after treatment with nifurtimox. Furthermore, the time at which seronegative conversion was detected was compared for ELISA F29 and conventional serological methods: recombinant ELISA, total purified antigen ELISA, and IHA.